KEAP1 and neoplasm: Notably, activation of NRF2 occurs in several malignancies through a variety of mechanisms, including mutations in KEAP1 or NRF2 that disrupt their interaction, epigenetic changes that influence NRF2 and KEAP1 expression, and chronic stress within the tumor microenvironment.49